Syndax Pharmaceuticals (SNDX) Other Gross PP&E Adjustments (2016 - 2025)
Syndax Pharmaceuticals (SNDX) has 11 years of Other Gross PP&E Adjustments data on record, last reported at -$694000.0 in Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 65.09% year-over-year to -$694000.0; the TTM value through Dec 2025 reached -$694000.0, up 65.09%, while the annual FY2025 figure was -$694000.0, 65.09% up from the prior year.
- Other Gross PP&E Adjustments reached -$694000.0 in Q4 2025 per SNDX's latest filing, up from -$1.5 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$694000.0 in Q4 2025 and bottomed at -$3.3 million in Q3 2023.
- Average Other Gross PP&E Adjustments over 5 years is -$1.8 million, with a median of -$1.8 million recorded in 2022.
- Peak YoY movement for Other Gross PP&E Adjustments: crashed 1183.33% in 2021, then skyrocketed 65.09% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$924000.0 in 2021, then plummeted by 113.42% to -$2.0 million in 2022, then decreased by 27.69% to -$2.5 million in 2023, then increased by 21.05% to -$2.0 million in 2024, then surged by 65.09% to -$694000.0 in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$694000.0 in Q4 2025, -$1.5 million in Q3 2025, and -$1.6 million in Q2 2025.